[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Nasal Flu Vaccine Market, Global Outlook and Forecast 2022-2028

April 2022 | 74 pages | ID: N75511148A3AEN
Market Monitor Global

US$ 3,250.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
It’s made from weakened flu viruses. Your doctor sprays it into your nose. It protects you from the flu viruses that could make you sick during the upcoming flu season.

This report contains market size and forecasts of Nasal Flu Vaccine in global, including the following market information:

Global Nasal Flu Vaccine Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Nasal Flu Vaccine Market Sales, 2017-2022, 2023-2028, (K Units)

Global top five Nasal Flu Vaccine companies in 2021 (%)

The global Nasal Flu Vaccine market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Trivalent Flu Vaccine Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Nasal Flu Vaccine include AstraZeneca. etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Nasal Flu Vaccine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Nasal Flu Vaccine Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Nasal Flu Vaccine Market Segment Percentages, by Type, 2021 (%)
  • Trivalent Flu Vaccine
  • Quadrivalent Flu Vaccine
Global Nasal Flu Vaccine Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Nasal Flu Vaccine Market Segment Percentages, by Application, 2021 (%)
  • Child
  • Adult
Global Nasal Flu Vaccine Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Nasal Flu Vaccine Market Segment Percentages, By Region and Country, 2021 (%)
  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Russia
    • Nordic Countries
    • Benelux
    • Rest of Europe
  • Asia
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Rest of Asia
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Middle East & Africa
    • Turkey
    • Israel
    • Saudi Arabia
    • UAE
    • Rest of Middle East & Africa
Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Nasal Flu Vaccine revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Nasal Flu Vaccine revenues share in global market, 2021 (%)

Key companies Nasal Flu Vaccine sales in global market, 2017-2022 (Estimated), (K Units)

Key companies Nasal Flu Vaccine sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:
  • AstraZeneca
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Nasal Flu Vaccine Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Nasal Flu Vaccine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL NASAL FLU VACCINE OVERALL MARKET SIZE

2.1 Global Nasal Flu Vaccine Market Size: 2021 VS 2028
2.2 Global Nasal Flu Vaccine Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Nasal Flu Vaccine Sales: 2017-2028

3 COMPANY LANDSCAPE

3.1 Top Nasal Flu Vaccine Players in Global Market
3.2 Top Global Nasal Flu Vaccine Companies Ranked by Revenue
3.3 Global Nasal Flu Vaccine Revenue by Companies
3.4 Global Nasal Flu Vaccine Sales by Companies
3.5 Global Nasal Flu Vaccine Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Nasal Flu Vaccine Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Nasal Flu Vaccine Product Type
3.8 Tier 1, Tier 2 and Tier 3 Nasal Flu Vaccine Players in Global Market
  3.8.1 List of Global Tier 1 Nasal Flu Vaccine Companies
  3.8.2 List of Global Tier 2 and Tier 3 Nasal Flu Vaccine Companies

4 SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Nasal Flu Vaccine Market Size Markets, 2021 & 2028
  4.1.2 Trivalent Flu Vaccine
  4.1.3 Quadrivalent Flu Vaccine
4.2 By Type - Global Nasal Flu Vaccine Revenue & Forecasts
  4.2.1 By Type - Global Nasal Flu Vaccine Revenue, 2017-2022
  4.2.2 By Type - Global Nasal Flu Vaccine Revenue, 2023-2028
  4.2.3 By Type - Global Nasal Flu Vaccine Revenue Market Share, 2017-2028
4.3 By Type - Global Nasal Flu Vaccine Sales & Forecasts
  4.3.1 By Type - Global Nasal Flu Vaccine Sales, 2017-2022
  4.3.2 By Type - Global Nasal Flu Vaccine Sales, 2023-2028
  4.3.3 By Type - Global Nasal Flu Vaccine Sales Market Share, 2017-2028
4.4 By Type - Global Nasal Flu Vaccine Price (Manufacturers Selling Prices), 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Nasal Flu Vaccine Market Size, 2021 & 2028
  5.1.2 Child
  5.1.3 Adult
5.2 By Application - Global Nasal Flu Vaccine Revenue & Forecasts
  5.2.1 By Application - Global Nasal Flu Vaccine Revenue, 2017-2022
  5.2.2 By Application - Global Nasal Flu Vaccine Revenue, 2023-2028
  5.2.3 By Application - Global Nasal Flu Vaccine Revenue Market Share, 2017-2028
5.3 By Application - Global Nasal Flu Vaccine Sales & Forecasts
  5.3.1 By Application - Global Nasal Flu Vaccine Sales, 2017-2022
  5.3.2 By Application - Global Nasal Flu Vaccine Sales, 2023-2028
  5.3.3 By Application - Global Nasal Flu Vaccine Sales Market Share, 2017-2028
5.4 By Application - Global Nasal Flu Vaccine Price (Manufacturers Selling Prices), 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Nasal Flu Vaccine Market Size, 2021 & 2028
6.2 By Region - Global Nasal Flu Vaccine Revenue & Forecasts
  6.2.1 By Region - Global Nasal Flu Vaccine Revenue, 2017-2022
  6.2.2 By Region - Global Nasal Flu Vaccine Revenue, 2023-2028
  6.2.3 By Region - Global Nasal Flu Vaccine Revenue Market Share, 2017-2028
6.3 By Region - Global Nasal Flu Vaccine Sales & Forecasts
  6.3.1 By Region - Global Nasal Flu Vaccine Sales, 2017-2022
  6.3.2 By Region - Global Nasal Flu Vaccine Sales, 2023-2028
  6.3.3 By Region - Global Nasal Flu Vaccine Sales Market Share, 2017-2028
6.4 North America
  6.4.1 By Country - North America Nasal Flu Vaccine Revenue, 2017-2028
  6.4.2 By Country - North America Nasal Flu Vaccine Sales, 2017-2028
  6.4.3 US Nasal Flu Vaccine Market Size, 2017-2028
  6.4.4 Canada Nasal Flu Vaccine Market Size, 2017-2028
  6.4.5 Mexico Nasal Flu Vaccine Market Size, 2017-2028
6.5 Europe
  6.5.1 By Country - Europe Nasal Flu Vaccine Revenue, 2017-2028
  6.5.2 By Country - Europe Nasal Flu Vaccine Sales, 2017-2028
  6.5.3 Germany Nasal Flu Vaccine Market Size, 2017-2028
  6.5.4 France Nasal Flu Vaccine Market Size, 2017-2028
  6.5.5 U.K. Nasal Flu Vaccine Market Size, 2017-2028
  6.5.6 Italy Nasal Flu Vaccine Market Size, 2017-2028
  6.5.7 Russia Nasal Flu Vaccine Market Size, 2017-2028
  6.5.8 Nordic Countries Nasal Flu Vaccine Market Size, 2017-2028
  6.5.9 Benelux Nasal Flu Vaccine Market Size, 2017-2028
6.6 Asia
  6.6.1 By Region - Asia Nasal Flu Vaccine Revenue, 2017-2028
  6.6.2 By Region - Asia Nasal Flu Vaccine Sales, 2017-2028
  6.6.3 China Nasal Flu Vaccine Market Size, 2017-2028
  6.6.4 Japan Nasal Flu Vaccine Market Size, 2017-2028
  6.6.5 South Korea Nasal Flu Vaccine Market Size, 2017-2028
  6.6.6 Southeast Asia Nasal Flu Vaccine Market Size, 2017-2028
  6.6.7 India Nasal Flu Vaccine Market Size, 2017-2028
6.7 South America
  6.7.1 By Country - South America Nasal Flu Vaccine Revenue, 2017-2028
  6.7.2 By Country - South America Nasal Flu Vaccine Sales, 2017-2028
  6.7.3 Brazil Nasal Flu Vaccine Market Size, 2017-2028
  6.7.4 Argentina Nasal Flu Vaccine Market Size, 2017-2028
6.8 Middle East & Africa
  6.8.1 By Country - Middle East & Africa Nasal Flu Vaccine Revenue, 2017-2028
  6.8.2 By Country - Middle East & Africa Nasal Flu Vaccine Sales, 2017-2028
  6.8.3 Turkey Nasal Flu Vaccine Market Size, 2017-2028
  6.8.4 Israel Nasal Flu Vaccine Market Size, 2017-2028
  6.8.5 Saudi Arabia Nasal Flu Vaccine Market Size, 2017-2028
  6.8.6 UAE Nasal Flu Vaccine Market Size, 2017-2028

7 MANUFACTURERS & BRANDS PROFILES

7.1 AstraZeneca
  7.1.1 AstraZeneca Corporate Summary
  7.1.2 AstraZeneca Business Overview
  7.1.3 AstraZeneca Nasal Flu Vaccine Major Product Offerings
  7.1.4 AstraZeneca Nasal Flu Vaccine Sales and Revenue in Global (2017-2022)
  7.1.5 AstraZeneca Key News

8 GLOBAL NASAL FLU VACCINE PRODUCTION CAPACITY, ANALYSIS

8.1 Global Nasal Flu Vaccine Production Capacity, 2017-2028
8.2 Nasal Flu Vaccine Production Capacity of Key Manufacturers in Global Market
8.3 Global Nasal Flu Vaccine Production by Region

9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS

9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints

10 NASAL FLU VACCINE SUPPLY CHAIN ANALYSIS

10.1 Nasal Flu Vaccine Industry Value Chain
10.2 Nasal Flu Vaccine Upstream Market
10.3 Nasal Flu Vaccine Downstream and Clients
10.4 Marketing Channels Analysis
  10.4.1 Marketing Channels
  10.4.2 Nasal Flu Vaccine Distributors and Sales Agents in Global

11 CONCLUSION

12 APPENDIX

12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

LIST OF TABLES

Table 1. Key Players of Nasal Flu Vaccine in Global Market
Table 2. Top Nasal Flu Vaccine Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Nasal Flu Vaccine Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Nasal Flu Vaccine Revenue Share by Companies, 2017-2022
Table 5. Global Nasal Flu Vaccine Sales by Companies, (K Units), 2017-2022
Table 6. Global Nasal Flu Vaccine Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Nasal Flu Vaccine Price (2017-2022) & (US$/Unit)
Table 8. Global Manufacturers Nasal Flu Vaccine Product Type
Table 9. List of Global Tier 1 Nasal Flu Vaccine Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Nasal Flu Vaccine Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Nasal Flu Vaccine Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Nasal Flu Vaccine Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Nasal Flu Vaccine Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Nasal Flu Vaccine Sales (K Units), 2017-2022
Table 15. By Type - Global Nasal Flu Vaccine Sales (K Units), 2023-2028
Table 16. By Application – Global Nasal Flu Vaccine Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Nasal Flu Vaccine Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Nasal Flu Vaccine Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Nasal Flu Vaccine Sales (K Units), 2017-2022
Table 20. By Application - Global Nasal Flu Vaccine Sales (K Units), 2023-2028
Table 21. By Region – Global Nasal Flu Vaccine Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Nasal Flu Vaccine Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Nasal Flu Vaccine Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Nasal Flu Vaccine Sales (K Units), 2017-2022
Table 25. By Region - Global Nasal Flu Vaccine Sales (K Units), 2023-2028
Table 26. By Country - North America Nasal Flu Vaccine Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Nasal Flu Vaccine Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Nasal Flu Vaccine Sales, (K Units), 2017-2022
Table 29. By Country - North America Nasal Flu Vaccine Sales, (K Units), 2023-2028
Table 30. By Country - Europe Nasal Flu Vaccine Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Nasal Flu Vaccine Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Nasal Flu Vaccine Sales, (K Units), 2017-2022
Table 33. By Country - Europe Nasal Flu Vaccine Sales, (K Units), 2023-2028
Table 34. By Region - Asia Nasal Flu Vaccine Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Nasal Flu Vaccine Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Nasal Flu Vaccine Sales, (K Units), 2017-2022
Table 37. By Region - Asia Nasal Flu Vaccine Sales, (K Units), 2023-2028
Table 38. By Country - South America Nasal Flu Vaccine Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Nasal Flu Vaccine Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Nasal Flu Vaccine Sales, (K Units), 2017-2022
Table 41. By Country - South America Nasal Flu Vaccine Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa Nasal Flu Vaccine Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Nasal Flu Vaccine Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Nasal Flu Vaccine Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa Nasal Flu Vaccine Sales, (K Units), 2023-2028
Table 46. AstraZeneca Corporate Summary
Table 47. AstraZeneca Nasal Flu Vaccine Product Offerings
Table 48. AstraZeneca Nasal Flu Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 49. Nasal Flu Vaccine Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 50. Global Nasal Flu Vaccine Capacity Market Share of Key Manufacturers, 2020-2022
Table 51. Global Nasal Flu Vaccine Production by Region, 2017-2022 (K Units)
Table 52. Global Nasal Flu Vaccine Production by Region, 2023-2028 (K Units)
Table 53. Nasal Flu Vaccine Market Opportunities & Trends in Global Market
Table 54. Nasal Flu Vaccine Market Drivers in Global Market
Table 55. Nasal Flu Vaccine Market Restraints in Global Market
Table 56. Nasal Flu Vaccine Raw Materials
Table 57. Nasal Flu Vaccine Raw Materials Suppliers in Global Market
Table 58. Typical Nasal Flu Vaccine Downstream
Table 59. Nasal Flu Vaccine Downstream Clients in Global Market
Table 60. Nasal Flu Vaccine Distributors and Sales Agents in Global Market

LIST OF FIGURES

Figure 1. Nasal Flu Vaccine Segment by Type
Figure 2. Nasal Flu Vaccine Segment by Application
Figure 3. Global Nasal Flu Vaccine Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Nasal Flu Vaccine Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Nasal Flu Vaccine Revenue, 2017-2028 (US$, Mn)
Figure 7. Nasal Flu Vaccine Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Nasal Flu Vaccine Revenue in 2021
Figure 9. By Type - Global Nasal Flu Vaccine Sales Market Share, 2017-2028
Figure 10. By Type - Global Nasal Flu Vaccine Revenue Market Share, 2017-2028
Figure 11. By Type - Global Nasal Flu Vaccine Price (US$/Unit), 2017-2028
Figure 12. By Application - Global Nasal Flu Vaccine Sales Market Share, 2017-2028
Figure 13. By Application - Global Nasal Flu Vaccine Revenue Market Share, 2017-2028
Figure 14. By Application - Global Nasal Flu Vaccine Price (US$/Unit), 2017-2028
Figure 15. By Region - Global Nasal Flu Vaccine Sales Market Share, 2017-2028
Figure 16. By Region - Global Nasal Flu Vaccine Revenue Market Share, 2017-2028
Figure 17. By Country - North America Nasal Flu Vaccine Revenue Market Share, 2017-2028
Figure 18. By Country - North America Nasal Flu Vaccine Sales Market Share, 2017-2028
Figure 19. US Nasal Flu Vaccine Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Nasal Flu Vaccine Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Nasal Flu Vaccine Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Nasal Flu Vaccine Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Nasal Flu Vaccine Sales Market Share, 2017-2028
Figure 24. Germany Nasal Flu Vaccine Revenue, (US$, Mn), 2017-2028
Figure 25. France Nasal Flu Vaccine Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Nasal Flu Vaccine Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Nasal Flu Vaccine Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Nasal Flu Vaccine Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Nasal Flu Vaccine Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Nasal Flu Vaccine Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Nasal Flu Vaccine Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Nasal Flu Vaccine Sales Market Share, 2017-2028
Figure 33. China Nasal Flu Vaccine Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Nasal Flu Vaccine Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Nasal Flu Vaccine Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Nasal Flu Vaccine Revenue, (US$, Mn), 2017-2028
Figure 37. India Nasal Flu Vaccine Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Nasal Flu Vaccine Revenue Market Share, 2017-2028
Figure 39. By Country - South America Nasal Flu Vaccine Sales Market Share, 2017-2028
Figure 40. Brazil Nasal Flu Vaccine Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Nasal Flu Vaccine Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Nasal Flu Vaccine Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Nasal Flu Vaccine Sales Market Share, 2017-2028
Figure 44. Turkey Nasal Flu Vaccine Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Nasal Flu Vaccine Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Nasal Flu Vaccine Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Nasal Flu Vaccine Revenue, (US$, Mn), 2017-2028
Figure 48. Global Nasal Flu Vaccine Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production Nasal Flu Vaccine by Region, 2021 VS 2028
Figure 50. Nasal Flu Vaccine Industry Value Chain
Figure 51. Marketing Channels


More Publications